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Abstract
Preeclampsia (PE) is a pregnancy disorder characterized by high blood pressure and proteinuria 
that can cause adverse health effects in both mother and fetus. There is no current cure for PE 
other than delivery of the fetus. While the etiology is unknown, poor placentation of the placenta 
due to aberrant signaling of growth and angiogenic factors has been postulated as causal factors of 
PE. In addition, environmental contaminants, such as the metal cadmium (Cd), have been linked to 
placental toxicity and increased risk of developing PE. Here, we use a translational study design to 
investigate genomic and epigenomic alterations in both placentas and placental trophoblasts, 
focused on the angiogenesis-associated transforming growth factor-beta (TGF-β) pathway. Genes 
within the TGF-β pathway displayed increased expression in both the preeclamptic placenta and 
Cd-treated trophoblasts. In addition, miRNAs that target the TGF-β pathway were also 
significantly altered within the preeclamptic placenta and Cd-treated trophoblasts. Integrative 
analysis resulted in the identification of a subset of Cd-responsive miRNAs, including miR-26a 
and miR-155, common to preeclamptic placentas and Cd-treated trophoblasts. These miRNAs 
have previously been linked to PE and are predicted to regulate members of the TGF-β pathway. 
Results from this study provide future targets for PE treatment.
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1. Introduction
Preeclampsia (PE) is a pregnancy-related condition characterized by hypertension and 
proteinuria during gestation, usually including damage to other organ systems, such as the 
kidneys (Chaiworapongsa et al. 2014). In the United States, PE affects between 5–8% of 
pregnancies and accounts for approximately 76,000 and 500,000 deaths of women and 
fetuses worldwide, respectively (Berg et al. 2010). While a precise etiology of PE is 
unknown, it is postulated that an underlying factor may be poor placentation due to 
inadequate angiogenesis (Chaiworapongsa et al. 2014; Saito and Nakashima 2014).
An array of ligands and receptors are known to tightly control angiogenesis. For example, 
growth factors, chemokines, cytokines, and endogenous angiogenesis inhibitors has been 
observed in the extracellular matrix (ECM) during vascularization (Brooks and Rathmell 
2014). Reduced placental blood flow upregulates expression of hypoxia inducible factor 1 
alpha (HIF1A), vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR), 
angiopoeitin-2 (ANGPT2), fibroblast growth factor-3 (FGF-3), nitric oxide synthase (NOS), 
and transforming growth factors (TGF-α, TGF-β1, TGF-β3) (Harris 2002). However in PE, 
the expression of anti-angiogenic factors such as fms-like tyrosin kinase-1 (FLT1) and its 
soluble form (sFLT1) are increased and can then bind to pro-angiogenic factors and inhibit 
angiogenic signaling (Nikuei et al. 2015). Proper placentation and vascular bed expansion 
has been found to be dependent on the expression of VEGF (Chaiworapongsa et al. 2014). 
On the other hand, the TGF-beta superfamily has been observed to oppose trophoblastic 
migration (Jones et al. 2006), suggesting an intricate balance of growth factor expression 
that is fundamental for placental health and embryo development (Nikuei et al. 2015; Conti 
et al. 2013).
Environmental exposure to toxic metals has been linked to placental toxicity/dysregulation 
causing improper vascularization in the placenta (Esteban-Vasallo et al. 2012; Lazebnik et 
al. 1989; Pollack et al. 2014). We have recently demonstrated a significant association 
between elevated levels of placental cadmium (Cd) and increased odds of developing PE 
(Laine et al. 2015), supporting an existing literature of this relationship (Pollack et al. 2014) 
Exposure to Cd can occur through multiple sources, including contaminated food and 
contaminated water sources, as well as cigarette smoke (Satarug et al. 2010). Alterations in 
the epigenetic landscape and genomic instability are potential detrimental human health 
effects of Cd exposure. Disruption of genomic stability has been highlighted as a feature of 
PE, which includes aberrant miRNA expression (Dai et al. 2012; Gao et al. 2012; Gunel et 
al. 2011; Ishibashi et al. 2012; Lazar et al. 2012; Li et al. 2013; Noack et al. 2011; Wang et 
al. 2012; Wu et al. 2012; Yang et al. 2011; Zhu et al. 2009) and DNA methylation alterations 
of the TGF-β pathway (Martin et al. 2015). Additional studies are needed to understand the 
underlying biology of Cd-associated risk of PE.
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In the present study, we used an integrated genomic analysis to examine Cd-driven 
regulation of the TGF-β pathway in PE, utilizing both clinical samples as well as in vitro 
experimentation in placental trophoblast cells. Our analysis incorporated placental 
expression of TGF-β pathway-associated genes and miRNA with placental Cd levels, and 
Cd-responsive TGF-β pathway-associated genes and miRNA in trophoblasts. This study 
aimed to examine the direct effects that Cd has on the genome and epigenome of placental 
cells in order to further elucidate the underlying biology that supports the pathology of PE 
and to provide future therapeutic targets for treatment.
2. Methods
Placental sample collection
Placentas from a total of 32 women (16 normotensive controls and 16 preeclamptic cases) 
were included in this study. The women received obstetric care at UNC hospitals and 
consented to collection of samples at the time of birth as detailed in our previous study 
(Martin et al. 2015). The American Congress of Obstetricians and Gynecologists diagnosed 
preeclampsia as sustained de novo hypertension (>140/90 mmHg) and proteinuria (>300mg 
of protein in a 24 h urine collection or urine protein/creatinine ratio of 0.3mg/dL) after 20 
weeks of pregnancy. All preeclamptic women displayed severe features of BP′>160/100 
with neurologic dysfunction, renal dysfunction, and/or evidence of HELLP syndrome. 
Women with confounding conditions such as pre-diabetes, diabetes, and gestational diabetes 
were excluded from the study. A full-thickness placental biopsy was obtained after delivery, 
avoiding the periphery and areas of obvious infarction, flash frozen in liquid nitrogen, and 
subsequently stored at -80C until analysis. Placental Cd concentrations were measured using 
ICP-MS as detailed (Laine et al. 2015). This research was approved by the Institutional 
Review Board at the University of North Carolina (#11-2054).
Cell culture methodology
JEG-3 cells, a human placental trophoblast cell line, were used for all cell culture analyses. 
This cell line maintains characteristics of first trimester trophoblast cells (Matsuo and 
Strauss 1994) and has been used to assess biological effects of exposures to environmental 
toxicants (Bergemann et al. 2003; Canettieri et al. 2008; Ding et al. 2011; Koc et al. 2003; 
Matscheski et al. 2006; Adebambo et al. 2015; Guan et al. 2013; Kummu et al. 2012; 
Alvarez and Chakraborty 2011). Cells were grown in Dulbecco’s Eagle Minimum Essential 
Media with 10% FBS, sodium pyruvate, and penicillin/streptomycin at 37°C with 5% CO2. 
Cd chloride (CdCl2) was dissolved into the media by vortex for final concentrations of 1, 10, 
and 25 uM.
Cell viability assay
Cells were seeded in 96-well black clear bottom plates at 10,000/mL with a total of 200uL 
of media. Three-fold dilutions of Cd chloride were carried out starting at 2,000 uM until a 
final concentration of 0.001uM was reached. Experiments were carried out in biological 
triplicate. Following a 24 or 48-hour incubation, media was removed and cell viability 
measured by the CellTiter-Glo Luminescent Cell Viability Assay (Promega, Madison, WI). 
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Luminescence was measured using a Promega GloMax Microplate Luminometer. IC10 and 
IC50 concentrations were established and used for subsequent experimentation.
Gene and miRNA expression
For clinical samples, a 0.2 g subsection of placental tissue was cut from each frozen biopsy 
on dry ice, washed briefly in sterile 1X PBS to remove any residual blood, and homogenized 
in Buffer RLT with B-mercaptoethanol (Qiagen, Valencia CA). DNA and RNA sequences 
greater than 18 nucleotides in length were collected using the AllPrep DNA/RNA/miRNA 
Universal Kit (Qiagen, Valencia CA) according to manufacturer’s instructions. RNA 
abundance was analyzed using the Affymetrix GeneChip ® Human Gene 2.0 ST array as 
described previously (Rager et al. 2014). Data were RMA processed using Partek Genomics 
Suite 6.4 (St Louis, Missouri). These data are available at the Gene Expression Omnibus 
(GEO) (GSE73377). For miRNAs, RNA was amplified, labeled, and hybridized on Agilent 
Human miRNA (8 × 60k) Oligo Microarrays. The green median signal was extracted and 
quantile normalized using Partek Genomics Suite 6.4 (St Louis, Missouri). These data are 
available at the Gene Expression Omnibus (GEO).
For the in vitro assays, both large and small RNAs were extracted simultaneously from 
JEG-3 cells using the Qiagen’s Allprep kit allowing the purification of a single fraction 
containing all RNA ≥ 18 nucleotides. The quantity of isolated RNA was measured with the 
Nanodrop 1000 spectrophotometer, and its integrity verified by the Agilent 2100 
Bioanalyzer. A total of 200ng of RNA was amplified, labeled, and hybridized on Agilent 
Human miRNA v.16 (8 × 60k) Oligo Microarrays. The green median signal was extracted 
and probes that expressed values of 1 deviation from the mean of the negative controls in 
more than 50% of the samples were removed. Resulting data were quantile normalized using 
Partek Genomics Suite 6.4 (St Louis, Missouri) and used for further analyses.
Real-time PCR analysis cDNA was generated using either Qiagen’s RT2 First Strand kit or 
miScript II RT Kit for gene and miRNA analysis, respectively. Quantitative real-time reverse 
transcriptase polymerase chain reaction (qRT-PCR) performed and assessed using the TGF-
β/BMP Signaling Pathway RT2 Profiler PCR Array (Valencia, CA), which tests 84 genes 
related to TGF-β signal transduction. Raw CT values from the RT2 Profiler PCR Arrays 
were analyzed for subsequent statistical testing. Validation of miRNAs was completed using 
Qiagen’s miScript Primer Assays and SYBR Green PCR kits. Experiments were carried out 
in biological triplicate, and any outliers removed prior to statistical analyses. The miRNA 
U6 was used as a housekeeping gene.
Statistical Analysis
To assess gene expression and miRNA differences between preeclamptic vs. non-
preeclamptic placentas, multivariable models were applied to the 53,637 probes on the 
Affymetrix GeneChip ® Human Gene 2.0 ST array and the 56,044 probes on the Agilent 
Human miRNA v.16 (8 × 60k) Oligo Microarrays. These models controlled for gestational 
age, maternal age and race. Differential RNA expression was statistically defined using a 
false discovery rate (FDR) corrected q≤0.15. Cd-associated mRNAs were analyzed 
separately among cases and controls using multivariable regression models. The models 
Brooks et al. Page 4
Food Chem Toxicol. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
controlled for maternal age, gestational age, race, and smoking. Statistical significance was 
again defined as q≤0.15. A database of miRNAs (n=651) was identified in association with 
canonical members of the TGF-β pathway involved in signal transduction using 
TargetScan7.0 (Lewis et al. 2003) and miRBase (Landgraf et al. 2007). Pearson correlation 
analysis was conducted for miRNAs to determine associations with their target mRNAs. 
Statistical significance was set at p<0.05.
T-tests were performed to assess statistical significance of the TGF-β Signaling Targets RT2 
Profiler PCR Array data using Qiagen’s Data Analysis Portal. CT values of the miRNA 
validation were used to calculate 2^ (−delta CT) values for cells exposed to 1uM or 10uM 
CdCl2 for 48-hours and controls and used for analysis of covariance (ANCOVA) to assess 
for differential miRNA expression. Differentially expressed miRNA transcripts were 
considered statistically significant if q ≤0.15.
3. Results
3.1 Dysregulation of TGF-β pathway-targeting miRNAs in the preeclamptic placenta
Gene expression was analyzed by genome-wide microarray with a subsequent focused 
analysis on 84-targeted TGF-β pathway-associated genes for 16 normotensive (control) and 
16 preeclamptic (cases) placentas, which resulted in the identification of a total of 31 TGF-β 
pathway genes that were significantly increased in the preeclamptic placenta (Supplemental 
Table 1). We set out to assess whether miRNAs may regulate the expression of these TGF-β-
associated genes. Of 651 compiled miRNAs that target canonical members of the TGF-β 
pathway, 109 were identified as differentially expressed in the preeclamptic placenta. These 
miRNAs tended to be upregulated in the preeclamptic placenta, where 63 miRNAs displayed 
increased expression and 46 miRNAs displayed decreased expression (Figure 1A, 
Supplemental Table 2). These identified TGF-β pathway-associated miRNAs were a subset 
of a broader genome-wide miRNA analysis where a total of 631 out of 861 (73%) tested 
human miRNAs were differentially expressed in the preeclamptic placenta, 17% (109 out of 
631) of which target the TGF-β pathway. Among these miRNAs are 52 that have previously 
been shown to be altered in preeclampsia (Harapan and Yeni 2015; D. b Chen and W. Wang 
2013) (Supplemental Table 2).
We next set out to examine the relationship between the TGF-β pathway-associated miRNAs 
and their target genes of interest. Among the 31 target genes were transforming growth 
factor beta-1 (TGFB1), transforming growth factor beta receptor 1 and 2 (TGFBR1/2), 
SMAD family member 2 (SMAD2), SMAD family member 3 (SMAD3), SMAD family 
member 4 (SMAD4), SMAD specific E3 ubiquitin protein ligase 1 (SMURF1), FBJ murine 
osteosarcoma viral oncogene homolog (FOS), serpin peptidase inhibitor, clade E, member 1 
(SERPINE1), and growth arrest and DNA damage inducible beta (GADD45B). When 
examining the relationship of TGF-β targeting miRNAs to the target genes of interest, 
Pearson correlation analysis identified a total of 128 significant miRNA-mRNA 
relationships; the identified associations were both negative (n=50) and positive (n=78) 
(Supplemental Table 3). While the relationship between the expression of miRNAs and their 
target mRNAs is generally expected to have an inverse association, these data highlight the 
complex mechanisms of miRNA regulation (Supplemental Table 3). Of the 31 TGF-β 
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pathway-associated genes, most (n=23, 74%) displayed a significant association with a 
TGFβ-associated miRNA suggesting a role for miRNAs as mediators of this pathway.
3.2 Cd-associated dysregulation of TGF-β pathway-targeting miRNAs in the preeclamptic 
placenta
Next, we performed multivariable regression analysis to test whether miRNA expression in 
the placenta was associated with placental Cd concentrations. Cd levels were assessed in 
both normotensive subjects (controls; range: 1.01–10.42 ng/g) and preeclamptics (cases; .
35–8.01 ng/g) and examined for their relationships to altered miRNA expression. As a 
result, 441 and 344 miRNAs were identified in controls and cases, respectively (Figure 1B). 
miRNAs that target the TGF-β pathway had robust expression changes in relation to Cd 
levels, with a subset of miRNAs (n=29) common to both cases and controls (Figure 1C). Cd 
levels were associated with substantial changes in the expression of miRNA targeting the 
TGF-β pathway in cases and controls, potentially highlighting distinct Cd-induced miRNA 
regulation that drive the development of PE.
3.3 Cd induces gene expression of the TGF-β pathway members in trophoblast cells
To better understand the relationship between Cd exposure and the regulation of the TGF-β 
pathway in the placenta, we performed in vitro experiments utilizing JEG-3 cells, a human 
placental trophoblast cell line. JEG-3 cells were exposed in culture to minimally cytotoxic 
(<5% cell death) concentrations of 1 and 10uM CdCl2 for 48 hours. These concentrations 
are similar to previous studies that have used low Cd concentrations (≤1uM) (Adebambo et 
al. 2015; Guan et al. 2013; Kummu et al. 2012) to evaluate biological disruptions in 
placental cells as a result of treatment, particularly anti-migratory effects that can influence 
risk of PE (Alvarez and Chakraborty 2011). Gene expression was analyzed by RT-PCR for 
84-targeted TGF-β pathway-associated genes using RNA isolated from untreated JEG-3 
cells or JEG-3 cells treated with Cd (Supplemental Table 4). Following a 48-hour 
incubation, five unique genes were significantly expressed in JEG-3 cells treated with either 
1uM or 10uM Cd concentrations compared to untreated cells (Figure 2A), with most (n=3) 
genes displaying increased expression in response to Cd.
We next analyzed the effects of Cd treatment on the TGF-β pathway-associated genes using 
the moderately cytotoxic (<50% cell death) concentration of 25uM CdCl2 for 24 and 48 
hours (Figure 2B). This concentration was selected as we aimed to contrast these cellular 
responses in vitro to PE, a disease attributed to placental toxicity. A total of 52 out of 84 
genes tested (62%) displayed significantly altered expression after the 24 or 48-hour Cd 
treatments (Figure 2B). Most of the significantly changed genes displayed increased 
expression in response to a 48-hour treatment of Cd. Specifically, at the 48-hour time point 
46 out of 49 genes showed an increase in expression, while 6 out of 10 genes were increased 
after the 24-hour treatment.
3.4 Cd activates the TGF-β pathway targeting miRNAs in trophoblast cells
Next, to investigate the regulation of the TGF-β pathway by miRNAs, a genome-wide 
miRNA microarray analysis was completed using cells treated with 48-hour 25uM CdCl2 
since it displayed the most robust genomic response to Cd. The expression levels of 99 out 
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of 651 TGF-β pathway-targeting miRNAs displayed significantly differential expression. 
The majority of these miRNAs displaying decreased expression (n=64) in relation to Cd 
(Figure 3A, Supplemental Table 1). These data demonstrate a general inverse relationship 
between Cd-induced gene expression of the TGF-β pathway and the Cd-induced repression 
of miRNAs that target the pathway. However, there were both positive (n=36) and negative 
(n=65) correlations between the expression of TGFB-associated miRNAs and their mRNA 
targets (Supplemental Table 5). These changes were a subset of a broader genome-wide Cd-
induced miRNA response where 466 miRNAs were significantly altered, with 181 
upregulated and 285 downregulated (Supplemental Table 1). Similar to the preeclamptic 
placenta, approximately 20% (99 out of 466) of the altered miRNAs in Cd-treated placental 
trophoblast cells target the TGF-β pathway.
To further examine Cd-responsive miRNAs in trophoblasts treated with the minimally 
cytotoxic concentrations, a total of six miRNAs were analyzed by quantitative PCR for their 
expression in JEG-3 cells treated with 1uM or 10uM concentrations of CdCl2 for 48 hours 
(Figure 3B). These miRNAs were selected because they were TGF-β-associated miRNAs 
significantly expressed in response to Cd in the preeclamptic placenta (miR-31* and 
miR-3677-5p), TGF-β-associated miRNAs previously established to be expressed in 
preeclamptic placenta (miR-26a and miR-155), or miRNAs that had significant expression 
in JEG-3 cells exposed to 25uM Cd for 48 hours (miR-3663-3p and miR-187*). Following 
ANOVA analysis, miR-155, miR-187*, and miR-3677-5p were significantly downregulated 
compared to control in the 1uM group, while miR-187* had significantly decreased 
expression in the 10uM group compared to control (Figure 3B). Similar to the gene 
expression data, the minimally cytotoxic Cd concentrations yielded fewer significantly 
expressed miRNAs in Cd-treated trophoblasts compared to the moderately cytotoxic Cd 
concentration. Interestingly, the TGFB-associated miR-3677-5p was significantly decreased 
in the 1 uM group while its predicted gene target bone morphogenetic proteins 5 (BMP5) 
(Garcia et al. 2011) was substantially increased (fold-change = 3.8) in response to Cd 
(Figure 2A), suggesting a possible Cd-driven miRNA mechanism for the regulation of the 
TGF-β pathway.
3.5 A comparison of Cd-associated dysregulation of the TGF-β pathway genes and 
targeting miRNAs in the preeclamptic placenta and placental trophoblast cells
After completing miRNA analysis in both placentas and placental cells, the 109 
differentially expressed TGF-β pathway-targeting miRNAs in the preeclamptic placenta and 
the 99 TGF-β pathway-targeting miRNAs expressed in the 48-hour 25uM Cd-treated 
trophoblasts were compared. Many (n=58) were common to both groups (Figure 4A). 
Furthermore, 15 TGF-β pathway-targeting miRNAs were associated with Cd in placental 
trophoblasts cells, the normotensive placenta, and the preeclamptic placenta (Figure 4B). 
miRNAs expressed in all three Cd-associated groups generally targeted ligands that activate 
the TGF-β pathway such as BMP2 and BMP5, as well as TGF-β pathway members 
responsible for signal transduction such as TGFBR1, SMAD1, SMAD2, and SMAD5. 
Specifically, miR-26a and miR-155, which target SMAD1 and SMAD2 respectively, were 
significantly differentially expressed in all three groups, with miR-155 significantly 
decreased in 48-hour 1uM Cd-treated trophoblast as well. Furthermore, these miRNAs were 
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observed to be associated with PE (Harapan and Yeni 2015), further bolstering a possible 
mechanism for Cd-associated PE.
Strong similarities of gene expression involving the TGF-β pathway were also noticeable 
between placenta and placental cells. Notably, 26 significantly expressed TGF-β pathway 
genes in Cd-treated placental trophoblast cells were present within the 31 genes altered in 
the preeclamptic placenta. Among these was TGF-β pathway members TGFBR1, TGFBR2, 
BMP2, and BMP5, which play key roles in the signal transduction of the TGF-β and BMP 
signaling pathways, and thus SMAD activation. Moreover, the downstream targets of these 
pathways, SMURF1, FOS, SERPINE1, and GADD45B, displayed increased expression in 
placenta and Cd-treated trophoblasts (Figure 5).
4. Discussion
In the present study, we set out to elucidate a potential molecular mechanism by which Cd 
exposure increases the risk for PE. Using a translational approach that integrates cell culture 
experimentation with clinical sample analysis, we establish a novel link between the 
induction of genes within the TGF-β pathway both in the preeclamptic placenta and in Cd-
exposed placental cells. Furthermore, we highlight miRNA suppression that may underlie 
the induction of the TGF-β pathway in response to Cd as an epigenetic mechanism that 
mediates expression. Investigating the underlying biology of PE and potential environmental 
influences can provide insight into the specific effects of toxicants on placental molecular 
phenotypes that increase risk of PE, as well as better treatment options for patients.
One of the main hypotheses for the development of PE is poor angiogenesis in the placenta 
leading to a hypoxic environment. Numerous growth factors exhibit aberrant maternal and 
placental expression in preeclamptic patients as compared to women who are normotensive 
during pregnancy (Nikuei et al. 2015). One family of growth factors is TGF-β, which 
promotes an anti-migratory signal in trophoblast cells. Here, we analyzed placentas from 
preeclamptic and normotensive women, as well as JEG-3 placental trophoblast cells treated 
with Cd, in order to investigate the induction of the TGF-β pathway. TGF-β receptors I and 
II were among the TGF-β pathway-associated genes that displayed increased expression in 
relation to PE as well as placental cells exposed to Cd. TGF-β receptors I and II activate the 
signal transduction of the TGF-β pathway upon the binding of the TGF-β superfamily of 
ligands. Further studies are needed to reveal how specifically Cd influences the TGF-β 
pathway in placentas and placental cells.
Currently, there are no treatment options for women with PE except for premature delivery 
of the placenta/fetus (Chaiworapongsa et al. 2014). Elucidating the molecular events that 
lead to PE can facilitate the development of safer treatment options. We hypothesized that 
not only could Cd alter expression of the TGF-β pathway in placentas and in placental 
trophoblasts, but also that the induction of the TGF-β pathway was regulated through 
miRNA-mediated mechanisms. We observed significant alterations of miRNAs that target 
genes associated with TGF-β in both the preeclamptic placenta and JEG-3 cells following 
treatment of Cd. In support of our findings, related to miRNA dysregulation of the 
preeclamptic placenta, we identified a total of 52 miRNAs that are dyregulated in the PE 
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placenta and overlap with other studies (D. B. Chen and W. Wang 2013). Among these are 
miRNAs belonging to the primate-specific miRNA gene cluster (C19MC) imprinted in the 
placenta including miR-517c, miR-518c, miR-519d, and miR-520h (Noguer-Dance et al. 
2010). Moreover, previous studies have elucidated associations of miR-26a and miR-155 
with PE, two miRNAs in our study that had significant Cd-altered expression in 
preeclamptic placenta, normotensive placenta, and JEG-3 cells treated with a moderate Cd 
concentration. SMAD1 and SMAD2, transcription factors that induce downstream TGF-β 
pathway genes, are predicted targets of miR-26a and miR-155 respectively and displayed 
altered gene expression in the preeclamptic placenta and in Cd-treated trophoblasts in this 
study; highlighting potential focuses for future studies to better understand Cd-mediated 
regulation of the TGF-β pathway.
While this study provides novel information on Cd-induced expression and epigenetic 
reprogramming that can further enhance our understanding of the genomic-epigenomic 
interactions that can drive preeclampsia, it is not without limitations. Further studies 
utilizing a larger clinical cohort of normotensive and preeclamptic women will be needed to 
validate these results and identify Cd-specific mechanism for miRNA-mediated regulation of 
angiogenic pathways, such as TGF-β. In addition, primary placental trophoblast cells should 
be used in future studies to identify Cd-specific phenotypes of genetic disruption. 
Furthermore, future studies should also involve a range of cytotoxic concentrations of Cd 
and other metals to examine the molecular regulation of the TGF-β pathway. Our data 
suggest higher Cd concentrations may be needed in vitro to observe comparable biological 
features of the preeclamptic placenta and that a miRNA feedback mechanism may be 
existent to contest the Cd-induced expression of the TGF-β pathway, highlighting the 
complexity of metal-induced toxicity in the placenta that can increase risk of PE.
Taken together our results demonstrate that miRNA dysregulation is a feature of PE and is 
enhanced with Cd exposure. In both the preeclamptic placenta and placental trophoblasts, 
dysregulated miRNA signaling was associated with altered expression signaling of the TGF-
β pathway, which may ultimately diminish trophoblast migratory capabilities. This study 
provides novel evidence of a relationship between Cd-induced expression and epigenetic 
reprogramming in the placenta that can further enhance our understanding of the interactions 
between environmental exposures and genetics that may drive preeclampsia.
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Figure 1. miRNA regulation of the TGF-β pathway regulation in the preeclamptic placenta
A. Differentially expressed TGF-β targeting miRNAs (n=109) from whole-genome miRNA 
microarray analysis between normotensive (Controls) and preeclamptic (Cases) placentas. 
B. All significantly expressed miRNAs associated with Cd exposure in Controls (n=441) and 
Cases (n=344). C. Differentially expressed TGF-β targeting miRNAs in Controls (n=85) and 
Cases (n=63) associated with Cd exposure.
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Figure 2. Cd alters the expression of the TGF-β pathway in placental trophoblast cells
Quantitative PCR results of differentially expressed genes within the TGF-β pathway and 
corresponding downstream targets in JEG-3 placental cells following treatment with 1uM or 
10uM CdCl2 for 48 hours (A) and 25uM CdCl2 for 24 and 48 hours (B).
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Figure 3. Expression of miRNAs that regulate the TGF-β pathway in Cd-treated trophoblast 
cells
A. Differential expression of TGF-β targeting miRNAs (n=99) from whole-genome miRNA 
microarray analysis in JEG-3 placental trophoblast cells treated with 25uM CdCl2 for 48 
hours. B. Quantitative PCR results of selected miRNAs in JEG-3 cells treated with 1uM or 
10uM CdCl2 for 48 hours. miR-155, miR-187*, and miR-3677 were significantly decreased 
in the 1uM group. The 10uM group expressed significant downregulation miR-187*. Cells 
treated with 1uM or 10uM CdCl2 were compared to untreated cells to determine fold-
change. ANOVA analysis was used to determine significance (*) that was defined as a p-
value less than 0.05 and a q-value less than 0.15.
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Figure 4. Venn diagram of TGF-β pathway targeting miRNAs in control or case placentas and 
trophoblast cells
TGF-β-targeting miRNAs uniquely expressed or overlapping among 25uM Cd-treated 
placental trophoblast cells and the preeclamptic placenta (A). TGF-β-targeting miRNAs 
uniquely expressed or overlapping among Cd-treated (25uM) placental trophoblast cells, and 
placentas (cases and controls) in association with Cd.
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Figure 5. Dysregulation of the TGF-β pathway in the preeclamptic placenta and Cd-treated 
placental trophoblast cells
Increased (up arrow) or decreased (down arrow) gene expression of canonical members of 
the TGF-β pathway in preeclamptic placenta and JEG-3 placental trophoblast cells treated 
with either minimum or moderate cytotoxic CdCl2 concentrations.
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